Target intelligence / Profile preview

Selenoprotein W (SELENOW)

Target
SELENOW
Molecular classification
Selenoprotein, Enzyme (glutathione-dependent antioxidant), Oxidoreductase (thioredoxin-like fold)
01

Overview

Selenoprotein W is a small selenoenzyme containing a selenocysteine residue at its active site, encoded by the SEPW1 gene. It is part of the SelWTH family with a thioredoxin-like fold, acting predominantly as a glutathione-dependent antioxidant protein and participating in redox regulation. SELENOW is highly expressed in muscle, heart, and brain. In muscle, SELENOW modulates proteostasis and is involved in the RAC1-mTOR signaling pathway, influencing protein synthesis and degradation. It also protects neurons from oxidative stress during development and has recently been identified as a key modulator of tau degradation and synaptic maintenance, implicating a role in Alzheimer’s disease and neurodegeneration. SELENOW’s expression is tightly regulated by selenium availability; deficiency is associated with certain diseases, including Keshan disease and potentially neurodegenerative pathologies.

Other names
SEPW1SELWSelenoprotein W1SelWselenoprotein W
02

Mechanism of action

For selenium or selenium-containing compounds: - Upregulates SELENOW expression, exerting antioxidant effects. - Promotes tau clearance via ubiquitin-proteasome pathway (in neurodegeneration). - Supports muscle proteostasis via SELENOW-RAC1-mTOR signaling cascade.

03

Biological functions

Redox signaling and antioxidant defenseModulation of cell cycleProtection from oxidative stressMuscle growth, differentiation, and proteostasisRegulation of tau degradation and synaptic maintenance
04

Disease associations

Alzheimer’s disease and other tauopathies (modulates tau homeostasis)Sarcopenia and muscle wastingKeshan disease (selenium deficiency)Pontocerebellar hypoplasia, Type 2D
05

Safety considerations

Therapeutic manipulation of selenium levels (via supplementation) must be performed cautiously, as excess selenium can cause toxicitySpecific targeting of SELENOW is not established; safety concerns would be inferred from global changes in redox biology and selenoprotein function
06

Biomarkers

SELENOW mRNA/protein levels may serve as biomarkers for selenium status, muscle atrophy, and potentially Alzheimer’s disease progression

Beyond the preview

Go deeper on Selenoprotein W (SELENOW).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selenoprotein W (SELENOW).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call